NF2F - Overview: Neurofilament (2F11) Immunostain, Technical Component Only
Aiding in the identification of neoplastic cells of neural origin or those exhibiting neuronal differentiation
FRAG - Overview: Osmotic Fragility, Erythrocytes
Evaluating suspected hereditary spherocytosis-associated hemolytic anemia Confirming or detecting mild spherocytosis
OXYSU - Overview: Oxycodone Screen, Random, Urine
Detection of oxycodone and oxymorphone in urine
MESOP - Overview: Mesothelioma Panel (WT1/KRT5/TTF1/pCEA) Immunostain, Technical Component Only
Differentiation of mesothelioma and non-small cell lung cancer
PNYA - Overview: Phenytoin, Total, Serum
Monitoring for appropriate therapeutic concentration Assessing compliance or toxicity
PRMB - Overview: Primidone and Phenobarbital, Serum
Assessing compliance Monitoring for appropriate therapeutic levels of primidone and phenobarbital Assessing toxicity
SUDC - Overview: Sudden Cardiac Death Pathology Consultation
Identifying specific causes contributing to sudden cardiac death
STLPC - Overview: St. Louis Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid
Aiding the diagnosis of St. Louis encephalitis using spinal fluid specimens
SDHB - Overview: SDHB Immunostain, Technical Component Only
Aids in the identification of succinate dehydrogenase B-deficient tumors
SOX10 - Overview: SOX10 Immunostain, Technical Component Only
Identification of malignant melanomas
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...